Bibliography
- CRONSTEIN BN: Adenosine, an endogenous anti,-inflammatory mediator. J. Appl. Physiol.(1994) 76:5–13.
- ••Pivotal review article.
- FOZARD JR, HANNON JP: Adenosine receptor ligands: potential, as therapeutic agents in asthma and COPD. Pulm. Pharmacol. Ther. (1999) 12(2):111–114.
- ••The background put by Novartis' former head of respiratoryR&D.
- ONGINI E, FREDHOLM BB: Pharmacology of adenosineA2A receptors. Trends Pharmacol. Sci. (1996) 17:364–372.
- LEVENS N, BEIL M, SCHULZ R: Intrarenal actions of thenew adenosine agonist CGS 21680A, selective for the A2 receptor. J. Pharmacol. Exp. Ther. (1 9 9 1) 2 5 7 (3)1013–1019.
- GLAXO WELLCOME: Corporate Development Pipeline.Press release (February 2000).
- KEELING SE, ALBINSON FD, AYRES BE et al.: Thediscovery and synthesis of highly potent, A2a receptor agonists. Bioorg. Med. Chem. Letts. 10(0403–406.
- NORMAN P: PDE4 inhibitors 1999. Exp. Opin. Ther.Patents (1999) 9(8):1101–1118.